BIO|MASTER.CSP Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 152 participants.

Also called NCT06620237

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 152 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06620237
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Belgium, France, Netherlands, New Zealand (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06620237. Non-randomized; no masking; primary purpose treatment. Start 2024-10-04 (actual); primary completion 2026-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIO|MASTER.CSP Study
Condition
Cardiac Pacing, Artificial
Condition
Cardiac Pacemaker, Artificial
Condition
Cardiac Resynchronization Therapy Devices
Condition
Bradycardia
Condition
Conduction Disorder
Condition
Conduction Defect, Cardiac
Condition
Heart Failure
Intervention (Device)
Implantation of the Solia CSP S pacing lead for LBBAP
Lead sponsor
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct06620237
Content hash
2233fa13f477b9c59d78dfa51c3192d91080f3082c4f5c88a9b5908765a2e7cd